Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Neurath MF et al. – Recent studies have provided important insights into the pathogenesis of inflammatory bowel disease (IBD). The development of new therapeutic agents has been triggered by basic research and studies in mouse models of IBD. It is expected that improved translational research will lead to optimized therapy and new individualized treatment options.

Related Articles

Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD
Gastroenterology Clinics of North America, 11/13/09    Relevance Score: 87%

Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel Disease
Digestive Diseases and Sciences, 10/19/09    Relevance Score: 87%

Safety Profile of IBD Therapeutics: Infectious Risks
Gastroenterology Clinics of North America, 11/17/09    Relevance Score: 85%

Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09    Relevance Score: 85%

Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: a proposed method
Alimentary Pharmacology and Therapeutics, 10/23/09    Relevance Score: 84%

Today in Gastrointestinal/Hepatic...keeping you current

SOCS3 in T and NKT Cells Negatively Regulates Cytokine Production and Ameliorates ConA-Induced Hepatitis
Journal of Immunology, 12/01/09

Identification of a Novel Antibody Associated with Autoimmune Pancreatitis
New England Journal of Medicine, 11/30/09

The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after entering the ileal mucosa
Infection and Immunity, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address